Captor Therapeutics Spolka Akcyjna (WSE: CTX)
Poland
· Delayed Price · Currency is PLN
57.40
+6.40 (12.55%)
Nov 20, 2024, 2:17 PM CET
CTX Balance Sheet
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 48.82 | 75.7 | 71.04 | 117.94 | 10.65 |
Short-Term Investments | - | - | 19.85 | - | - |
Cash & Short-Term Investments | 48.82 | 75.7 | 90.89 | 117.94 | 10.65 |
Cash Growth | -10.81% | -16.71% | -22.94% | 1007.03% | - |
Accounts Receivable | 3.53 | 6.37 | 0.98 | 0.97 | 0.02 |
Other Receivables | 2.87 | 6.2 | 8.7 | 10.73 | 1.73 |
Receivables | 6.4 | 12.57 | 9.68 | 11.71 | 1.75 |
Prepaid Expenses | - | 0.09 | 0.07 | 0.06 | 0.02 |
Other Current Assets | - | 0.29 | 0.68 | 0.85 | 0.81 |
Total Current Assets | 55.22 | 88.65 | 101.32 | 130.56 | 13.25 |
Property, Plant & Equipment | 8.04 | 6.95 | 10.67 | 12.61 | 12.2 |
Other Intangible Assets | 0.23 | 0.31 | 0.6 | 0.18 | 0.14 |
Long-Term Deferred Charges | 0.99 | 1.17 | 0.18 | 0.18 | 0.18 |
Other Long-Term Assets | 0.16 | 0.22 | 0.23 | 0.01 | 0.01 |
Total Assets | 64.63 | 97.29 | 113 | 143.54 | 25.78 |
Accounts Payable | 4.91 | 6.5 | 5.65 | 3.19 | 2.36 |
Accrued Expenses | 8.93 | 9.41 | 1.48 | 2.25 | 1.15 |
Current Portion of Leases | 2.95 | 2.53 | 3.72 | 5.24 | 5.73 |
Current Income Taxes Payable | - | 0.96 | 1.35 | 0.9 | 0.36 |
Current Unearned Revenue | 4.05 | 7.18 | 0.13 | 0.13 | 10.4 |
Other Current Liabilities | - | 0.15 | 1.08 | 4.66 | - |
Total Current Liabilities | 20.84 | 26.73 | 13.39 | 16.37 | 20.01 |
Long-Term Debt | - | - | - | - | 0.21 |
Long-Term Leases | 2.57 | 1.25 | 3.24 | 2.94 | 6.5 |
Total Liabilities | 23.52 | 28.07 | 16.68 | 19.34 | 26.78 |
Common Stock | 0.47 | 0.47 | 0.42 | 0.41 | 0.36 |
Additional Paid-In Capital | 208.88 | 208.88 | 170.03 | 170.03 | 16.29 |
Retained Earnings | -194.35 | -164.69 | -94.1 | -58.21 | -25.64 |
Comprehensive Income & Other | 26.11 | 24.56 | 19.98 | 11.97 | 7.98 |
Shareholders' Equity | 41.11 | 69.22 | 96.32 | 124.2 | -1 |
Total Liabilities & Equity | 64.63 | 97.29 | 113 | 143.54 | 25.78 |
Total Debt | 5.52 | 3.78 | 6.95 | 8.18 | 12.45 |
Net Cash (Debt) | 43.3 | 71.93 | 83.94 | 109.76 | -1.79 |
Net Cash Growth | -13.77% | -14.31% | -23.53% | - | - |
Net Cash Per Share | 8.68 | 15.48 | 20.14 | 26.59 | -0.50 |
Filing Date Shares Outstanding | 4.66 | 4.65 | 4.17 | 4.13 | 3.59 |
Total Common Shares Outstanding | 4.66 | 4.65 | 4.17 | 4.13 | 3.59 |
Working Capital | 34.38 | 61.92 | 87.93 | 114.19 | -6.76 |
Book Value Per Share | 8.82 | 14.90 | 23.11 | 30.09 | -0.28 |
Tangible Book Value | 40.88 | 68.91 | 95.72 | 124.02 | -1.15 |
Tangible Book Value Per Share | 8.77 | 14.83 | 22.96 | 30.04 | -0.32 |
Buildings | 19.11 | 14.94 | 13.84 | 9.77 | 8.2 |
Machinery | 20.47 | 19.92 | 19.61 | 24.85 | 18.75 |
Source: S&P Capital IQ. Standard template. Financial Sources.